Advisor Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$2.21M Sell
48,905
-6,731
-12% -$282K 0.02% 763
2019
Q3
$2.26M Sell
55,636
-1,770
-3% -$75K 0.02% 708
2019
Q2
$2.47M Sell
57,406
-7,887
-12% -$303K 0.02% 675
2019
Q1
$2.51M Buy
65,293
+11,171
+21% +$427K 0.02% 640
2018
Q4
$1.91M Buy
54,122
+22,544
+71% +$818K 0.02% 655
2018
Q3
$1.22M Buy
31,578
+7,057
+29% +$246K 0.01% 870
2018
Q2
$803K Buy
24,521
+7,998
+48% +$241K 0.01% 991
2018
Q1
$451K Sell
16,523
-763
-4% -$20.7K 0.01% 1393
2017
Q4
$429K Buy
17,286
+1,530
+10% +$42.2K 0.01% 1425
2017
Q3
$460K Sell
15,756
-8,796
-36% -$243K 0.01% 1261
2017
Q2
$680K Buy
24,552
+9,853
+67% +$261K 0.01% 953
2017
Q1
$365K Buy
14,699
+2,628
+22% +$63.9K 0.01% 1257
2016
Q4
$261K Sell
12,071
-12,032
-50% -$263K 0.01% 1377
2016
Q3
$573K Buy
24,103
+11,099
+85% +$265K 0.01% 901
2016
Q2
$302K Buy
+13,004
New +$281K 0.01% 1201

Other funds holding BSX

Advisor Group's BSX Position: Q4 2019 in Review

Advisor Group reduced its Boston Scientific (BSX) stake by 12% in Q4 2019, selling an estimated $282K and leaving 48,905 shares worth $2.21M. The position accounts for 0.02% of the portfolio, ranked #763.

Advisor Group first reported a position in BSX in Q2 2016 and has held it in 15 quarters since. The position peaked at $2.51M in Q1 2019. 853 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

  • Advisor Group held 48,905 shares of Boston Scientific worth $2.21M as of Q4 2019.
  • Advisor Group sold 6,731 Boston Scientific shares in Q4 2019, an estimated $282K.
  • Boston Scientific made up 0.02% of Advisor Group's portfolio in Q4 2019, its #763 holding.
  • Advisor Group first reported a position in Boston Scientific in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Boston Scientific position peaked at $2.51M in Q1 2019.
  • 853 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.